Modulation of transmitter release via presynaptic cannabinoid receptors

Trends in Pharmacological Sciences

Volumn 22, Issue 11, 2001, Pages 565-572

  Schlicker, Eberhard ^a   Kathmann, Markus ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N MORPHOLINO 1H PYRAZOLE 3 CARBOXAMIDE; 2 ARACHIDONOYLGLYCEROL; 2 METHYL 3 (1 NAPHTHOYL) 1 PROPYLINDOLE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 4 [6 METHOXY 2 (4 METHOXYPHENYL) 3 BENZOFURANYLCARBONYL]BENZONITRILE; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; ANANDAMIDE; CANNABINOID; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; CANNABIS; DEXANABINOL; LIGAND; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; RIMONABANT; UNCLASSIFIED DRUG; WIN 552123;

AMNESIA; CENTRAL NERVOUS SYSTEM; DRUG ACTIVITY; DRUG MECHANISM; HUMAN; NEUROTRANSMITTER RELEASE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; SIDE EFFECT;

ANIMALS; CANNABINOIDS; HUMANS; NEUROTRANSMITTER AGENTS; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; RECEPTORS, PRESYNAPTIC;

EID: 0035499974     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(00)01805-8     Document Type: Review

References (79)

1. Marijuana and medicine: Assessing the science base. A summary of the 1999 Institute of Medicine report
2. Adverse effects of cannabis
3. 2 receptors
4. Pharmacology of cannabinoid receptor ligands
5. The effects of cannabinoids on the brain
6. Pharmacological and biochemical interactions between opioids and cannabinoids
7. Preliminary experiments on the chemistry and pharmacology of cannabis
8. Morphine- and anandamide-stimulated nitric oxide production inhibits presynaptic dopamine release
9. Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists
10. 1 receptor-mediated functional effects in rat hippocampus are decreased by an intracerebroventricularly administered antisense oligodeoxynucleotide
11. 1 receptor-deficient mice
12. Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations
13. Pharmacological characterization of three novel cannabinoid receptor agonists in the mouse isolated vas deferens
14. 2-like cannabinoid receptors on peripheral nerve terminals
15. Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens
16. + M-current in hippocampal CA1 neurons
17. 3H]noradrenaline from mouse cultured sympathetic neurons: Release-modulating heteroreceptors
18. Mechanism of cannabinoid effects on long-term potentiation and depression in hippocampal CA1 neurons
19. Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons
20. Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures
21. Mechanisms of cannabinoid-receptor-mediated inhibition of synaptic transmission in cultured hippocampal pyramidal cells
22. A synaptic transmission in the hippocampus
23. Occlusion of the presynaptic action of cannabinoids in rat substantia nigra pars reticulata by cadmium
24. Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens
25. Cannabinoid receptor modulation of synapses received by cerebellar Purkinje cells
26. 2+ and cAMP
27. Production and physiological actions of anandamide in the vasculature of the rat kidney
28. 1 receptors
29. Cannabinoid receptor-mediated inhibition of acetylcholine release from hippocampal and cortical synaptosomes
30. Pharmacological analysis of cannabinoid receptor activity in the rat vas deferens
31. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses
32. Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals
33. Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells
34. Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra
35. Cannabinoid transmission and reward-related events
36. 1 opioid receptor mechanism
37. The dopamine hypothesis of reward: Past and current status
38. Neuronal localization of cannabinoid receptors in the basal ganglia of the rat
39. Effects of cannabinoids on dopamine release in the corpus striatum and the nucleus accumbens in vitro
40. Lack of response suppression follows repeated ventral tegmental cannabinoid administration: An in vitro electrophysiological study
41. Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: A comparison with opioids
42. Cannabinoids inhibit GABAergic synaptic transmission in mice nucleus accumbens
43. Cellular and molecular mechanisms underlying learning and memory impairments produced by cannabinoids
44. Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats
45. Effects of the endogenous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices
46. The septohippocampal pathway: Structure and function of a central cholinergic system
47. Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55,212-2, and is potentiated by the cannabinoid antagonist, SR 141716A
48. Inhibition of hippocampal acetylcholine release by cannabinoids: Reversal by SR 141716A
49. Cannabinoid CB1 receptor-mediated inhibition of acetylcholine release in the brain of NMRI, CD-1 and C57BL/6J mice
50. Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716
51. 1 receptor knock-out mice
52. 1 receptor-mediated inhibition of noradrenaline release in the human and guinea-pig hippocampus
53. GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus
54. Presynaptic cannabinoid and imidazoline receptors in the human heart and their potential relationship
55. 1 receptors in human ileum
56. Effects of cannabinoids on sympathetic and parasympathetic neuroeffector transmission in the rabbit heart
57. Effect of the cannabinoid receptor agonist WIN 55,212-2 on sympathetic cardiovascular regulation
58. Cannabinoid receptor-mediated inhibition of dopamine release in the retina
59. 1 receptors in guinea-pig small intestine
60. Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig myenteric plexus
61. Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons
62. 1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons
63. Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum
64. Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum
65. CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum
66. Cannabinoids inhibit excitatory neurotransmission in the substantia nigra pars reticulata
67. Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal gray neurons in vitro
68. Cannabinoids decrease excitatory synaptic transmission and impair long-term depression in rat cerebellum
69. Cannabinoid receptor activation inhibits GABAergic neurotransmission in rostral ventromedial medulla neurons in vitro
70. 1 receptors on peripheral sympathetic nerves
71. 1 receptor-mediated inhibition of the neurogenic vasopressor response in the pithed rat
72. 1 receptors
73. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice
74. 1 receptor knockout mice
75. 3H-noradrenaline release by presynaptic opioid, cannabinoid and bradykinin receptors and β-adrenoceptors in mouse tissues
76. 1 receptors in mouse urinary bladder
77. 1 receptors on presynaptic inhibitory terminals in cultured rat hippocampal neurons
78. Effect of the cannabinoid receptor SPECT agent, AM 281, on hippocampal acetylcholine release from rat brain slices
79. 8-tetrahydrocannabinol in two isolated tissue preparations